Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15021311

J. Acquir. Immune Defic. Syndr. 2004 Apr 15 35 5 464-72

Download in:

View as

Triples

General Info

PMID
15021311